Literature DB >> 30046224

Incidence and mortality of laryngeal cancer in China, 2008-2012.

Yuqin Liu1, Qin Zhao1, Gaoheng Ding1, Yitong Zhu1, Wenying Li1, Wanqing Chen2.   

Abstract

OBJECTIVE: To analyze the incidence and mortality rates of laryngeal cancer in China from 2008 to 2012.
METHODS: Incident and death cases of laryngeal cancer were retrieved from the National Central Cancer Registry (NCCR) database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of laryngeal cancer were calculated by area (urban/rural), region (eastern, middle, western), gender and age group (0, 1-4, 5-9, …, 85+). China census in 2000 and Segi's world population were applied for age standardized rates. JoinPoint (Version 4.5.0.1) model was used for time trend analysis.
RESULTS: The crude incidence rate of laryngeal cancer was 1.86/100,000 ranked the 21st in overall cancers. The age-standardized incidence rates by China population (ASIRC) and by World population (ASIRW) were 1.22/100,000 and 1.23/100,000, respectively. The crude mortality of laryngeal cancer in China was 1.01/100,000 and it was the 21st cause of cancer-related death in overall cancers. Both the age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 0.63/100,000. Incidence and mortality rates of laryngeal cancer were higher in males than in females and higher in urban areas than in rural areas. Middle areas had the highest incidence and mortality rates followed by eastern and western areas. Incidence and mortality rates of laryngeal cancer retained low level before age of 40 years old but increased greatly after and peaked in age group of 75. Incidence showed significant down trends in recent 10 years by 1.27% annually [95% confidence interval (95% CI): -2.2%, -0.3%]. Mortality declined in females sharply by 5.18% per year although stable in males and both sexes combined.
CONCLUSIONS: Appropriate targeted prevention, early detection and treatment programs should be carried out to control the local burden of laryngeal cancer.

Entities:  

Keywords:  China; Laryngeal cancer; incidence; mortality

Year:  2018        PMID: 30046224      PMCID: PMC6037590          DOI: 10.21147/j.issn.1000-9604.2018.03.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  15 in total

1.  [Incidence and mortality of larynx cancer in China during 2003-2007].

Authors:  Ling-bin Du; Wei-min Mao; Wan-qing Chen; Si-wei Zhang; Chuan-ding Yu; Rong-shou Zheng; Qing-min Xia; Xiang-hui Wang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-04

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

3.  Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.

Authors:  Takahide Taguchi; Goshi Nishimura; Masahiro Takahashi; Masanori Komatsu; Daisuke Sano; Naoko Sakuma; Yasuhiro Arai; Yukiko Yamashita; Osamu Shiono; Mariko Hirama; Yasunori Sakuma; Jun-ichi Ishitoya; Masaharu Hata; Ichiro Ogino; Nobuhiko Oridate
Journal:  Cancer Chemother Pharmacol       Date:  2013-10       Impact factor: 3.333

4.  Incidence and mortality of laryngeal cancer in China, 2011.

Authors:  Lingbin Du; Huizhang Li; Chen Zhu; Rongshou Zheng; Siwei Zhang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  A rare association of leiomyosarcoma with squamous cell carcinoma of the larynx: two cases.

Authors:  E Kara; M F Cetik; U Tuncer; A Uguz
Journal:  J Laryngol Otol       Date:  2013-08-07       Impact factor: 1.469

7.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

8.  Laryngeal cancer incidence and mortality in China, 2010.

Authors:  Shuang-Shuang Zhang; Qing-Min Xia; Rong-Shou Zheng; Wan-Qing Chen
Journal:  J Cancer Res Ther       Date:  2015-10       Impact factor: 1.805

9.  Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Tingting Zuo; Changfa Xia; Zhixun Yang; Jie He
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

10.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

View more
  9 in total

1.  Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms.

Authors:  Yajing Du; Shali Shao; Minghe Lv; Yi Zhu; Li Yan; Tiankui Qiao
Journal:  Front Oncol       Date:  2020-08-26       Impact factor: 6.244

2.  LPCANet: Classification of Laryngeal Cancer Histopathological Images Using a CNN with Position Attention and Channel Attention Mechanisms.

Authors:  Xiaoli Zhou; Chaowei Tang; Pan Huang; Francesco Mercaldo; Antonella Santone; Yanqing Shao
Journal:  Interdiscip Sci       Date:  2021-06-17       Impact factor: 2.233

3.  Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm-Coagulation-Blood-Stasis Syndrome via the STAT3/Cyclin D1 Pathway.

Authors:  Xi Tan; Qiulan Luo; Shiqing Zhou; Wei Huang; Xiaocong Feng; Wenyong Chen; Chaojie Yang; Yunying Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-22       Impact factor: 2.629

4.  MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro.

Authors:  Chaoping Huang; Zhenxiao Wang; Kun Zhang; Yanbo Dong; Aobo Zhang; Cheng Lu; Liangfa Liu
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

5.  Epidemiological Analysis of 1234 Cases of Laryngeal Cancer in Shanxi Province, China.

Authors:  Hui Qi; Wenjie Chen; Chunming Zhang; Xiwang Zheng; Chen Peng; Qinli Zhao; Yujia Guo; Yongyan Wu; Wei Gao; Binquan Wang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

6.  A metabolomics strategy to identify potential biomarkers associated with human laryngeal cancer based on dried blood spot mass spectrometry approach.

Authors:  Xue Wu; Yongting Liu; Huaixuan Ao; Peng Yang; Zhitu Zhu
Journal:  Medicine (Baltimore)       Date:  2022-02-25       Impact factor: 1.817

7.  Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma.

Authors:  Mengdie Hu; Shujun Zhang
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

8.  Potential prognostic markers and significant lncRNA-mRNA co-expression pairs in laryngeal squamous cell carcinoma.

Authors:  Junguo Wang; Dingding Liu; Yajun Gu; Han Zhou; Hui Li; Xiaohui Shen; Xiaoyun Qian
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

9.  Incidence and mortality of laryngeal cancer in China, 2015.

Authors:  Yutong He; Di Liang; Daojuan Li; Baoen Shan; Rongshou Zheng; Siwei Zhang; Wenqiang Wei; Jie He
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.